Sales Associate – USA
Sales Associate Read More
News
Texcell Expands Its Commercial Presence in Japan
TEXCELL, announces the opening of its subsidiary in Japan to offer a viral security services solution to biotechs and pharmaceutical industries in Japan. Bernard PLICHON, Chairman and CEO (chief executive officer) of the TEXCELL group: “After expanding its viral safety... Read More
Detection of low viral contamination on CHO cells culture using Next Generation Sequencing
(Poster presented at BioProcess International European Summit, 25-27 April 2017, RAI, Amsterdam.) Texcell patented sample preparation technology allows genome viral detection by NGS with an increase of viral sequence presence and a diminution of background genomic DNA. Detection of low... Read More
MockV Solutions Announces Collaboration with Texcell N.A. to Assess MVP Technology
Rockville, MD – April 24, 2017 – MockV Solutions, Inc. (MockV or the Company), a biotechnology company developing non-infectious viral clearance prediction products that address the unmet needs of process development scientists as they establish biopharmaceutical manufacturing platforms, announced today... Read More
Press Release – Texcell, now a Pharmaceutical Establishment
Press release TEXCELL now a « Pharmaceutical Establishment » TEXCELL, a supplier of services in viral security, immunology and toxicology for the past 20 years, is now a « Pharmaceutical Establishment » meeting Good Manufacturing Practice (GMP) requirements for its viral security... Read More